antibiotic resistance

The PCR diagnostic device is a palm-size, single-use, disposable device that detects N. gonorrhoeae and determines if it's susceptible to an antibiotic.

The company, formerly known as Klaris Diagnostics, plans to use the funding to work toward US FDA clearance of its clinical microbiology diagnostics platform.

The funds will support a platform for rapid bacterial identification and antimicrobial resistance testing.

Roche will have non-exclusive access to SpeeDx's existing tests and technology to enable expansion of diagnostic products for antibiotic resistance in STIs.

The additional funds will be used to advance the development of the company's Next Generation Phenotyping technology through clinical trials.

The company's revenue was largely attributed to its Acuitas AMR Gene Panel and Acuitas Lighthouse informatics platform.

The Swedish firms plans to launch clinical performance studies in support of getting CE marking for its QuickMIC system.

OpGen also reported full-year growth was driven by revenue increases for its Acuitas AMR Gene Panel and Acuitas Lighthouse informatics platform.